WO2002090339A1 - A process for preparing 1-methyl-3-phenyl-piperazine - Google Patents

A process for preparing 1-methyl-3-phenyl-piperazine Download PDF

Info

Publication number
WO2002090339A1
WO2002090339A1 PCT/IN2002/000117 IN0200117W WO02090339A1 WO 2002090339 A1 WO2002090339 A1 WO 2002090339A1 IN 0200117 W IN0200117 W IN 0200117W WO 02090339 A1 WO02090339 A1 WO 02090339A1
Authority
WO
WIPO (PCT)
Prior art keywords
stirring
phenyl
piperazine
temperature
product
Prior art date
Application number
PCT/IN2002/000117
Other languages
French (fr)
Inventor
Davuluri Ramamohan Rao
Chunduru Sankara Rao
Pamujula Sreenivasulu
Original Assignee
Neuland Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuland Laboratories Limited filed Critical Neuland Laboratories Limited
Publication of WO2002090339A1 publication Critical patent/WO2002090339A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Definitions

  • the present invention pertains to the pharmaceutical industry in general novel process for preparing 1- Methyl-3-phenyl piperazine without impurities.
  • Patent 4772705 wherein its preparation was reported as starting from cthylenc diaminc and ethyl a- bromophenyl acetate in absolute ethanol to give 3-phenyl-2-pipcrazinone which on reduction with lithium aluminium hydride in anhydrous ether gave 2-phenyl piperazine which was methylated with methyl iodide in presence of acetone and triethvlamine and isolated as its hydrochloride in 54% yield. Methylation of 2-phenyl piperazine by this method gives undesired side products, which are difficult to be eschewed or removed. The above process is time consuming and expensive. Besides the obtained process is full of impurities.
  • a process for preparing l-Methyl-3-phenyl-p ⁇ peraz ⁇ ne which comprises: (i) mixing l-Benzyl-2-phenyl piperazine with formic acid solution while stirring and then with formaldehyde solution and heating the mixture to a temperature of 70°C to 80°C for 50 to 70 minutes;
  • Step (ii) reheating the obtained solution of Step (i) to a temperature of
  • Step (iv) washing the product of Step (iii) with water and drying to obtain l-Bcnzyl-4-mcthyl-2-phenyl piperazine;
  • Step (v) adding the product of Step (iv) with acetic acid taken in hydrogenator in the presence of palladium-carbon catalyst under nitrogen atmosphere while continuously stirring the mixture for about
  • Methyl-3-phenyl piperazine is highly imperative for preparation of the anti-depressant drug, which is known as Mirtazapine.
  • l-Methyl-3-phenyl piperazine is free from impurities.
  • reaction mass gets added to sodium hydroxide solution (5% w/v; 2800 ml) by maintaining the temperature below 25°C.
  • sodium hydroxide solution 5% w/v; 2800 ml
  • the contents get stirred for one hour and thereby filtered.
  • the product is then washed with water (1000 ml), sucked well and dried to a constant weight at 50 to 55 (J C to yield 361g of the product (m.p
  • Acetic acid is distilled completely under vacuum, demineralised water (300 ml) is added to the residue and to this under stirring sodium hydroxide solution (50% w/v, 400ml) gets added maintaining the temperature below 25°C.
  • the contents are then extracted twice with hexane (1000 ml and 500 ml).
  • the hexane layer is concentrated to 200 ml, cooled 0 to 5°C, stirred for 50 to 70 minutes at 0 to 5 ⁇ C and filtered.
  • the product is then washed with chilled hexane (50 ml), sucked well dried to a constant weight in an air oven to yield 106g of the product, (m.p. 53 to 55°C, 80.1% yield).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A process for preparing 1-Methyl-3-phenyl-piperazine, which comprises: (i) mixing 1-Benzyl-2-phenyl-piperazine with formic acid solution while stirring and then with formaldehyde solution and heating the mixture to a temperature of 70 °C to 80 °C for 50 to 70 minutes; (ii) reheating the obtained solution of Step (i) to a temperature of 90 to 95 °C for 50 to 70 minutes; (iii) checking the obtained mass of Step (ii) for the absence of the starting material (TLC system, Toluene: IMS=6:4) and treating with sodium hydroxide solution while stirring for 50 to 70 minutes at a temperature of below 25 °C and filtering; (iv) washing the product of Step (iii) with water and drying to obtain 1-Benzyl-4-methyl-2-phenyl piperazine; (v) adding the product of Step (iv) with acetic acid taken in hydrogenator in the presence of palladium-carbon catalyst under nitrogen atmosphere while continuously stirring the mixture for about 6 to 10 hours keeping hydrogen pressure of 3.5 to 4.0 kg/cm2; (vi) checking the product of Step (v) for the absence of the starting material (TLC system, Ethyl acetate: Methanol = 1:1) and filtering under nitrogen and distilling acetic acid completely under vacuum; (vii) stirring the residue of Step (vi) with demineralised water and stirring with sodium hydroxide solution at a temperature up to 25 °C and extracting at least twice with hexane; (viii) concentrating the hexane layer to the mass of Step (vii) followed by stirring and filtering at a temperature of O to 5 °C, (ix) treating the product of Step (viii) with chilled hexane and drying in an air oven to obtain 1-Methyl-3-phenyl-piperazine.

Description

Field of Invention
At the very outset, to put it succincdy, the present invention pertains to the pharmaceutical industry in general novel process for preparing 1- Methyl-3-phenyl piperazine without impurities.
Prior Art
For preparation of the drug substance viz., Mirtazapine which is an anti depressant drug, 1 -Methyl -3-phenyl piperazine is a key intermediate. Long time ago i.e., on September 20, 1998, the preparation of l-iVfethy-3- phenyl piperazine was reported in U.S. Patent 4772705 wherein its preparation was reported as starting from cthylenc diaminc and ethyl a- bromophenyl acetate in absolute ethanol to give 3-phenyl-2-pipcrazinone which on reduction with lithium aluminium hydride in anhydrous ether gave 2-phenyl piperazine which was methylated with methyl iodide in presence of acetone and triethvlamine and isolated as its hydrochloride in 54% yield. Methylation of 2-phenyl piperazine by this method gives undesired side products, which are difficult to be eschewed or removed. The above process is time consuming and expensive. Besides the obtained process is full of impurities.
Summary of the Invention
It has, therefore, been long felt need to develop a process which is easy and cost effective.
According to the present invention there is provided a process for preparing l-Methyl-3-phenyl-pιperazιne, which comprises: (i) mixing l-Benzyl-2-phenyl piperazine with formic acid solution while stirring and then with formaldehyde solution and heating the mixture to a temperature of 70°C to 80°C for 50 to 70 minutes;
(ii) reheating the obtained solution of Step (i) to a temperature of
90 to 95°C for 50 to 70 mmutes;
(iii) checking the obtained mass of Step (ii) for the absence of the starting material (TLC system, Toluene: IMS = 6:4) and treating with sodium hydroxide solution while stirring for 50 to 70 minutes at a temperature of below 25°C and filtering;
(iv) washing the product of Step (iii) with water and drying to obtain l-Bcnzyl-4-mcthyl-2-phenyl piperazine;
(v) adding the product of Step (iv) with acetic acid taken in hydrogenator in the presence of palladium-carbon catalyst under nitrogen atmosphere while continuously stirring the mixture for about
6 to 10 hours keeping hydrogen pressure of 3.5 to 4.0kg/ cm"; (vi) checking the product of Step (v) for the absence of the starting material (TLC system, Kthyl acetate: Methanol = 1: 1) and filtering under nitrogen and distilling acetic acid completely under vacuum; (vii) stirring the residue of Step (vi) with dcmincralised water and stirring with sodium hydroxide solution at a temperature up to 25 C and extracting at least twice with hexane;
(viii) concentrating the hexane layer to the mass of Step (vii) followed by stirring and filtering at a temperature of 0 to 5 C; (ix) treating the product of Step (viii) with chilled hexane and drying in an air oven to obtain l-Methyl-3-ρhenyl-ρiρcrazine. In the developed process the retained l-Methyl-3-phenyl piperazine is derived sans impurities. Besides, as stated earlier, this 1-
Methyl-3-phenyl piperazine is highly imperative for preparation of the anti-depressant drug, which is known as Mirtazapine. In the obtained process l-Methyl-3-phenyl piperazine is free from impurities.
We shall now describe the invention in detail: -
L Preparation of l-Benzyl-4 methyl-2-phenyl piperazine - To put it succinctly, l-Benzyl-2 phenyl piperazinem (355.2 g. 1.41 moles) gets added to formic acid's stirred solution (85% w/w/; 190g 3.51 moles), which is being followed by fomaldehyde solution (35% w/w/; 145g. 1.69 moles). The contents get heated to and maintained for one hour at 70 to 80°C. Then, contents are heated to and maintained for 50 to 70 minutes at 90 to 95°C. A sample of the reaction mass is checked for the absence of the starting material (TLC system, Toluene: IMS = 6:4). Then the reaction mass gets added to sodium hydroxide solution (5% w/v; 2800 ml) by maintaining the temperature below 25°C. The contents get stirred for one hour and thereby filtered. The product is then washed with water (1000 ml), sucked well and dried to a constant weight at 50 to 55(JC to yield 361g of the product (m.p
73-76°C, yield 96.3%). The material then gets directly taken sans further purification to the next stage.
2. Preparation of l-Methyl-3-phenyl piperazine - l-Benzyl-4-methyl- 2-phenyl piperazine (200g), 5% palladium-carbon catalyst (lOg, 50% wet) and Acetic acid (1000 ml), which is taken in hydrogenator, are added under nitrogen atmosphere. The contents are then stirred under 3.5 to 4.0 kg/cm hydrogen pressure for 6 to 10 hours. A sample of the reaction mass is checked for the absence of the starting material (TLC system, Ethyl acetate: Methanol=l : l ). The reaction mass gets filtered under nitrogen atmosphere. Acetic acid is distilled completely under vacuum, demineralised water (300 ml) is added to the residue and to this under stirring sodium hydroxide solution (50% w/v, 400ml) gets added maintaining the temperature below 25°C. The contents are then extracted twice with hexane (1000 ml and 500 ml). The hexane layer is concentrated to 200 ml, cooled 0 to 5°C, stirred for 50 to 70 minutes at 0 to 5ϋC and filtered. The product is then washed with chilled hexane (50 ml), sucked well dried to a constant weight in an air oven to yield 106g of the product, (m.p. 53 to 55°C, 80.1% yield).
The foregoing description is only illustrative of the present invention it is not intended that the invention be limited thereto. Many other specific embodiments of the present invention will be obvious and apparent to one skilled in the art from the foregoing disclosure. All substitution, changes, alterations and modification of the present invention which come within the scope of the following claims are to which the present invention is readily susceptible without departing from the spirit of the invention.

Claims

CLAIMS :
1. A process for preparing l-Methyl-3-phenyl-piperazine, which comprises:
(i) mixing l-Benzyl-2-phenyl piperazine with formic acid solution while stirring and then with formaldehyde solution and heating the mixture to a temperature of 70°C to 80°C for 50 to 70 minutes;
(ii) reheating the obtained solution of Step (i) to a temperature of 90 to 95°C for 50 to 70 minutes;
(iii) checking the obtained mass of Step (ii) for the absence of the starting material (TLC system, Toluene: IMS = 6:4) and treating with sodium hydroxide solution while stirring for 50 to 70 minutes at a temperature of below 25°C and filtering;
(iv) washing the product of Step (iii) with water and drying to obtain l-Benzyl-4-methyl -2-phenyl piperazine; (v) adding the product of Step (iv) with acetic acid taken in hydrogenator in the presence of palladium-carbon catalyst under nitrogen atmosphere while continuously stirring the mixture for about 6 to 10 hours keeping hydrogen pressure of 3.5 to 4.0kg/ cm2;
(vi) checking the product of Step (v) for the absence of the starting material (ILC system, Ethyl acetate: Methanol = 1:1) and filtering under nitrogen and distilling acetic acid completely under vacuum;
(vii) stirring the residue of Step (vi) with demineralised water and stirring with sodium hydroxide solution at a temperature up to 25 C and extracting at least twice with hexane; (viii) concentrating the hexane layer to the mass of Step (vii) followed by stirring and filtering at a temperature of 0 to 5 C; (ix) treating the product of Step (viii) with chilled hexane and drying in an air oven to obtain l-Mcthyl-3-phenyl-piperazine.
2. The process as claimed in Claim 1, which involves protection and deportection of one of the nitrogen atoms of the peperazine ring before and after methylation.
3. The process as claimed in Claim 1, which utilizes formic acid and formaldehyde for methylation.
4. The process as claimed in Claim 1 , which utilizes acetic acid as the solvent for debcnzylation.
5. The process as claimed in Claim 1, which utilizes hexane as solvent for the purification of l-Mcthyl-3-phenyl piperazine.
6. l-Methyl-3-phenyl piperazine wherever prepared by process as claimed in any one of Claims 1 to 5 or otherwise thereof
PCT/IN2002/000117 2001-05-08 2002-05-06 A process for preparing 1-methyl-3-phenyl-piperazine WO2002090339A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN364/MAS/2001 2001-05-08
IN364CH2001 2001-05-08

Publications (1)

Publication Number Publication Date
WO2002090339A1 true WO2002090339A1 (en) 2002-11-14

Family

ID=11096997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2002/000117 WO2002090339A1 (en) 2001-05-08 2002-05-06 A process for preparing 1-methyl-3-phenyl-piperazine

Country Status (1)

Country Link
WO (1) WO2002090339A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004106309A1 (en) * 2003-06-02 2004-12-09 Aurobindo Pharma Ltd A process for preparing 1-methyl-3-phenylpiperazine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772705A (en) * 1985-07-25 1988-09-20 Pennwalt Corporation Processes for the preparation of trans 1,3,4,6,7,11b-hexahydro-7-aryl-2H-pyrazinol[2,1-a]isoquinolines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772705A (en) * 1985-07-25 1988-09-20 Pennwalt Corporation Processes for the preparation of trans 1,3,4,6,7,11b-hexahydro-7-aryl-2H-pyrazinol[2,1-a]isoquinolines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004106309A1 (en) * 2003-06-02 2004-12-09 Aurobindo Pharma Ltd A process for preparing 1-methyl-3-phenylpiperazine
US7041826B2 (en) * 2003-06-02 2006-05-09 Aurobindo Pharma Ltd. Process for preparing 1-methyl-3-phenylpiperazine using a novel intermediate

Similar Documents

Publication Publication Date Title
CN114685468A (en) Intermediate compound of medicine for treating hysteromyoma and preparation method thereof
KR100346672B1 (en) Method for preparing 3-O-substituted ascorbic acid
CA1185609A (en) 2-(hydroxy-phenyl) indoles and process for producing same
WO2002090339A1 (en) A process for preparing 1-methyl-3-phenyl-piperazine
JP4817527B2 (en) Method for producing piperidine
WO2019174101A1 (en) Method for preparing tenofovir
WO2019097112A1 (en) Synthesis of a 2-indolinone derivative known as intermediate for preparing nintedanib
JP2002520313A5 (en)
CN111620788B (en) Method for preparing (2S,3S) -3-amino-bicyclo [2.2.2] octane-2-formic ether
CN110563659B (en) Method for preparing 1,2, 3-triazole compound by heterogeneous copper catalysis in one pot
JP2019522662A (en) New method for producing Vemurafenib
Niclas et al. A Novel Synthetic Route to 2-Aryl-2H-Benzotriazole 1-Oxides
CN111925324A (en) Synthetic method of 3-acyl quinoline compound
CN108084002B (en) Preparation method of 2-hydroxyphenyl propiophenone
US4980505A (en) Organic synthesis
NO318881B1 (en) Process for the preparation of isoindoline
JPH04290877A (en) Process for producing symmetric 2,2'-methylenebisbenzotriazolyl phenols
CN110922421B (en) Synthesis method of N-methyl-1, 2,5, 6-tetrahydropyridine-4-boric acid pinacol ester
CN113372317B (en) Industrial production method of tetrahydro-2H-pyran-3-one
CN101735132A (en) Synthesis method of N-methyl-2-hydroxyethyl hydroxyethyl
CN114409556A (en) Preparation method of 3, 4-disubstituted-2-aminobenzaldehyde
KR101856586B1 (en) Preparation method of 13-Bromo-10H-phenanthro[9,10-b]carbazole
JP2675137B2 (en) Process for producing (cis-2-butenyl) dimethylchlorosilane
JPH0149265B2 (en)
CN117304000A (en) Preparation method of 2-substituted triphenylene derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP